Chapter 9: Pharmacotherapy of Pain Management

Pain is defined as a subjective, unpleasant sensory and emotional experience, and the chapter categorizes it based on underlying source—nociceptive (resulting from mechanical, thermal, or chemical insult, further divided into somatic and visceral pain), neuropathic (caused by abnormal central nervous system signaling), or mixed syndromes. Physiologically, pain transmission is described through nociception, a four-step process including transduction (nociceptor activation), transmission (signal movement to the brain via A-delta and C fibers and the dorsal horn), perception (conscious awareness influenced by psychological factors), and modulation (attenuation by endogenous opioids, serotonin, and nor-epinephrine). The progression from acute, purposeful pain to persistent, chronic pain often involves changes in the nervous system resulting in peripheral and central sensitization and neuroinflammation, leading to conditions like allodynia and hyperalgesia. Management must utilize thorough assessment (e.g., PQRSTU, NRS, VAS) to determine severity and type, guiding the selection of appropriate pharmacologic and non-pharmacologic modalities. Treatment typically starts with nonopioid analgesics for mild-to-moderate pain, such as acetaminophen (often used around-the-clock for mild, noninflammatory pain) or NSAIDs (which inhibit COX-1 and COX-2 to reduce inflammation but carry GI and cardiovascular risks). For moderate-to-severe pain, opioid agonists (like morphine, the gold standard) are utilized, often in a multimodal approach, requiring careful assessment due to the risks of tolerance, physical dependence, and Opioid Use Disorder (OUD). Specialized agents like methadone (a dual mu-receptor agonist and NMDA antagonist) and fentanyl are important options, particularly in patients with renal or liver failure, as their metabolites are less neurotoxic than those of morphine. For chronic and neuropathic conditions, co-analgesics are essential, including antidepressants (TCAs and SNRIs like duloxetine) and anticonvulsants (gabapentinoids like gabapentin and pregabalin) that help modulate pain signals.